Healwell AIHWAIF -2.09%58 9-Day RSI is 39.75 as of Jul. 06, 2026. GuruFocus rates HWAIF with a GF Score™ of 58/100 and a GF Value™ of $2.55 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 697 Healthcare Providers & Services companies, Healwell AI ranks better than 90.24% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-06), Healwell AI's 9-Day RSI is 39.75.
The industry rank for Healwell AI's 9-Day RSI or its related term are showing as below:
HWAIF's 9-Day RSI is ranked better than 90.24% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 52.67
vs HWAIF: 39.75
Healwell AI (OTCPK:HWAIF) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Healwell AI 9-Day RSI Related Terms
HWAIF vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Healwell AI's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healwell AI 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Healwell AI's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Healwell AI's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healwell AI (HWAIF) has a 9-Day RSI of 39.75 as of Jul. 06, 2026. According to the industry distribution chart, Healwell AI ranks #68 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 9.8%.
Is Healwell AI's 9-Day RSI too high?
Healwell AI's current 9-Day RSI is 39.75. The Healthcare Providers & Services industry median 9-Day RSI is 52.67. Healwell AI's value of 39.75 is 24.5% below this industry median. Based on the distribution chart, Healwell AI ranks #68 out of 697 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Healwell AI has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Healwell AI's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Healwell AI ranks #68 out of 697 companies for 9-Day RSI. This places Healwell AI in the top 10% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 52.67. Healwell AI's value of 39.75 is 24.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 52.67, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healwell AI's current 9-Day RSI of 39.75 is 24.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 52.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healwell AI's current 9-Day RSI is 39.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healwell AI stock overvalued right now?
Based on GuruFocus' analysis, Healwell AI (HWAIF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.55, compared to a current price of $0.54 — trading 78.9% below its estimated fair value. The current 9-Day RSI is 39.75 and 24.5% below the Healthcare Providers & Services industry median of 52.67. Healwell AI's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Healwell AI (HWAIF), the current 9-Day RSI is 39.75 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healwell AI (HWAIF) Overvalued in 2026?
Based on GuruFocus' analysis, Healwell AI stock appears to be undervalued.
The current stock price of $0.54 is trading 78.9% below its estimated GF Value™ of $2.55.
GuruFocus considers Healwell AI to be Possible Value Trap.
Key valuation signals for HWAIF:
9-Day RSI: 39.75
GF Value™: $2.55 vs. price of $0.54 (78.9% below fair value)
Industry Position: 24.5% below the Healthcare Providers & Services median (#68 of 697)
No single metric tells the full story. See the HWAIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healwell AI Inc is a Canadian healthcare technology company. It operates in two reportable segments: Al and Data Sciences, and Healthcare Software. The majority of Healwell's revenue is generated from the Healthcare Software segment, whose core software suite consists of Electronic Health Records (EHR), Digital Front Door (DFD), and Digital Care Records (DCR). These products consolidate diverse data sources, helping physicians get a comprehensive view of individual patient health. The AI and Data Sciences division offers AI technologies and algorithms that screen clinical information and patient records, and aid in identifying patients at high risk for specific conditions. Geographically, the company generates maximum revenue from Australia and New Zealand, and the rest from Canada.
58GF Score
Get the complete analysis for HWAIF
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HWAIF has been successfully added to your 